Ras versus cyclin-dependent kinase inhibitors
- 1 February 1998
- journal article
- review article
- Published by Elsevier in Current Opinion in Genetics & Development
- Vol. 8 (1) , 43-48
- https://doi.org/10.1016/s0959-437x(98)80060-9
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Proliferative lifespan checkpoints: Cell-type specificity and influence on tumour biologyEuropean Journal Of Cancer, 1997
- Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4aCell, 1997
- Ras signalling is required for inactivation of the tumour suppressor pRb cell-cycle control proteinCurrent Biology, 1997
- Inactivation of the Cyclin D-dependent Kinase in the Rat Fibroblast Cell Line, 3Y1, Induced by Contact InhibitionPublished by Elsevier ,1997
- Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors.The Journal of cell biology, 1996
- Abrogation of p27 by cDNA Antisense Suppresses Quiescence (G0 State) in FibroblastsJournal of Biological Chemistry, 1996
- Stimulation of Membrane Ruffling and MAP Kinase Activation by Distinct Effectors of RASScience, 1996
- Regulation of the cell cycle by viral oncoproteinsSeminars in Cancer Biology, 1995
- ras GENESAnnual Review of Biochemistry, 1987
- In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenesCell, 1986